Related Experiment Video
Updated: Jul 18, 2026
08:55
The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
Published on: November 30, 2016
Muscle cachexia is regulated by a p53-PW1/Peg3-dependent pathway.
Martina Schwarzkopf1, Dario Coletti, David Sassoon
1Brookdale Department of Molecular, Cell, and Developmental Biology, Mount Sinai Medical School, New York, New York 10029, USA.
Genes & Development
|December 22, 2006
Summary
The p53 protein is crucial for muscle wasting (cachexia) by inhibiting muscle stem cell regeneration. Blocking PW1, a protein interacting with p53, prevents muscle atrophy in tumor-bearing mice, suggesting new therapeutic targets.
Area of Science:
- Molecular biology
- Cellular biology
- Physiology
Background:
- Muscle wasting, or cachexia, is an incurable condition linked to chronic infections and cancer, significantly impairing recovery.
- Tumor necrosis factor-alpha (TNFalpha), a key inflammatory cytokine, drives cachexia by inhibiting muscle stem cell differentiation and regeneration.
- TNFalpha exerts its effects through the p53 cell death pathway, involving downstream factors like PW1/Peg3, bax, and caspases.
Purpose of the Study:
- To investigate the role of p53 in TNFalpha-mediated inhibition of myogenesis and its contribution to muscle wasting.
- To elucidate the regulatory relationship between p53 and PW1 in muscle stem cell function.
- To explore the therapeutic potential of targeting the p53-PW1 pathway for treating muscle wasting.
Main Methods:
- In vitro studies examining TNFalpha's effect on myogenesis in the presence and absence of p53.
- In vivo studies using p53 nullizygous mice to assess stem cell populations.
- In vivo gene transfer of dominant-negative PW1 to evaluate its impact on tumor-induced muscle atrophy.
Main Results:
- p53 is essential for TNFalpha's inhibition of myogenesis in vitro and contributes to muscle wasting in vivo.
- A positive feedback loop exists between PW1 and p53 in vitro.
- p53 deficiency leads to a significant reduction in skeletal muscle stem cells expressing PW1.
- Inhibition of PW1 function in vivo prevents muscle fiber atrophy associated with tumor load.
Conclusions:
- p53 plays a critical role in regulating muscle stem cell behavior and mediating muscle atrophy.
- The p53-PW1 interaction represents a novel pathway involved in cachexia.
- Targeting the p53-PW1 axis offers a promising therapeutic strategy for combating muscle wasting.
Related Concept Videos
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
01:23Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.